TransMedics Stock Falls as Q3 Earnings & Sales Miss Estimates

TransMedics Group, Inc. (TMDX) reported third-quarter 2024 earnings per share (EPS) of 12 cents, which missed the Zacks Consensus Estimate of 28 cents by 57.1%. The company recorded a loss per share of 78 cents in the year-ago period. TransMedics registered revenues of $108.8 million, up 63.9% year over year. The figure, however, missed the Zacks Consensus Estimate by 4.8%. The year-over-year increase in sales was driven by the increase in utilization of the Organ Care System (OCS) across all three organs a ...